Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (351-360 of 8,370) with videos related to

Pageof 837
Sort By:
Drugs|January 1, 1988
Diabetes and atherosclerosis. Metabolic linksG Steiner
Drugs|January 1, 1988
Cholesterol reduction and coronary artery disease. An overview of clinical trials up to 1986M J Tikkanen, K Pyörälä
Drugs|January 1, 1988
Regression of coronary atherosclerosis. Angiographic perspectiveD D Waters, J Lespérance
Drugs|January 1, 1988
Interaction of lipoproteins with the artery wallN Woolf
Drugs|January 1, 1988
Normal and pathological lipoprotein metabolismG R Thompson
Drugs|January 1, 1988
Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternativeE E Slater, J S MacDonald
Drugs|January 1, 1988
The present status of anti-inflammatory agents in dermatologyG Stüttgen
Drugs|January 1, 1988
Pinacidil. Preclinical investigationsI Ahnfelt-Rønne
Drugs|January 1, 1988
Effects of pinacidil on bladder muscleK E Andersson, P O Andersson, M Fovaeus, et al.
Drugs|January 1, 1988
Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertensionJ E Carlsen, H A Jensen, M Rehling, et al.
Pageof 837

Showing results (351-360 of 8,370) with videos related to

Sort By:
Pageof 837
Drugs|January 1, 1988
Diabetes and atherosclerosis. Metabolic linksG Steiner
Drugs|January 1, 1988
Cholesterol reduction and coronary artery disease. An overview of clinical trials up to 1986M J Tikkanen, K Pyörälä
Drugs|January 1, 1988
Regression of coronary atherosclerosis. Angiographic perspectiveD D Waters, J Lespérance
Drugs|January 1, 1988
Interaction of lipoproteins with the artery wallN Woolf
Drugs|January 1, 1988
Normal and pathological lipoprotein metabolismG R Thompson
Drugs|January 1, 1988
Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternativeE E Slater, J S MacDonald
Drugs|January 1, 1988
The present status of anti-inflammatory agents in dermatologyG Stüttgen
Drugs|January 1, 1988
Pinacidil. Preclinical investigationsI Ahnfelt-Rønne
Drugs|January 1, 1988
Effects of pinacidil on bladder muscleK E Andersson, P O Andersson, M Fovaeus, et al.
Drugs|January 1, 1988
Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertensionJ E Carlsen, H A Jensen, M Rehling, et al.
Pageof 837